Enter your search terms:

MonoSol Rx to Present at Cowen & Company 29th Annual Health Care Conference

Warren, NJ (March 12, 2009) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, today announced that A. Mark Schobel, president and CEO, and Keith J. Kendall, executive vice president and CFO, are scheduled to present at the Cowen & Company 29th Annual Health Care Conference to be held on March 16 – 19 at the Boston Marriott Copley Place in Boston.

Mr. Schobel and Mr. Kendall will also be available to respond to questions immediately following the presentation and to participate in one-on-one meetings with investors attending the conference.

Event: Cowen & Company 29th Annual Health Care Conference

Date:   Tuesday, March 17, 2009

Time:   8:30 a.m. ET

Place:           MIT room, 3rd Floor, Boston Marriott Copley Place, Boston, MA

About MonoSol Rx

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in quick dissolving films. PharmFilm® is designed to benefit patients by improving the convenience, efficacy, and compliance of currently marketed drugs. The Company is a leader in thin film drug delivery and has a strong intellectual property position, a portfolio of commercialized OTC drug products, and a pipeline of prescription formulations utilizing its PharmFilm® technology. With a vertically integrated development and production infrastructure, MonoSol Rx has the capacity to manufacture OTC drug products for near-term revenues that enable the funding of prescription product development programs that will generate long-term value.

The Company’s commercialization strategy for all PharmFilm® products is to partner with the innovator or other specialty pharma or leading consumer products companies who have the core competency to sell-in and manage the sales and marketing of the products. For the Company’s existing and future partners, PharmFilm® formulations represent revenue-life cycle extensions for products with patent lives that have expired or are approaching expiration.  PharmFilm® is also a tool to help sales and marketing partners differentiate in competitive markets while offering unique advantages over drugs dosed by traditional tablets, capsules and ODTs.

Latest comments

Sorry, the comment form is closed at this time.